Vimarsana
Biggest News Aggregation in the World

Page 23 - Biobehavioral Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biobehavioral Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biobehavioral Sciences Today - Breaking & Trending Today

COVID-19 vaccines aren't getting to those in need. Blame the broadband gap - Vimarsana News

COVID-19 vaccines aren't getting to those in need. Blame the broadband gap

For many seniors and people of color, technology is a barrier to getting the vaccine.

Source: cnet.com
COVID-19 vaccine is tough to find unless you're an internet genius with broadband - Vimarsana News

COVID-19 vaccine is tough to find unless you're an internet genius with broadband

For many seniors and people of color, technology is a barrier to getting the vaccine.

Source: cnet.com
World Renowned Ophthalmologist Dr. Patricia Bath Could Be First Black Woman Inducted into the National Inventors Hall of Fame - Vimarsana News

World Renowned Ophthalmologist Dr. Patricia Bath Could Be First Black Woman Inducted into the National Inventors Hall of Fame

Dr. Patricia Bath In 1986, she invented the Laserphaco Probe for cataract treatment, one of the most important surgical tools in the history of ophthalmology, where she used the Excimer Laser to develop a device and method for minimally invasive cataract surgery. In 1988, Dr. Bath became the first Black woman to receive a medical patent [U.S. Patent No. 4,744,360]. Her illustrious career included being awarded five U.S. patents. Her method has helped eye surgeons restore or improve vision for millions of patients worldwide. Of the twenty million cataract surgeries performed worldwide annuall...

Lundquist Institute receives $1.75 million grant from Steven & Alexandra Cohen Foundation - Vimarsana News

Lundquist Institute receives $1.75 million grant from Steven & Alexandra Cohen Foundation

 E-Mail LOS ANGELES (February 10, 2021) -- The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness. The grant will also support education and outreach programs related to the use of psilocybin within the field of palliative care. This innovative and first-of-its-kind psychedelic study will be conducted at several leading medical schools and cancer centers ...